PFE Pfizer Earnings and EPS analysis

EPS in 2026 (TTM): $1.31

Last Report Period Date: Mar 29, 2026

Based on the company's latest reports for March 2026, the current 12-month EPS is $1.31. Pfizer's earnings per share in 2025 was reported at $1.37, marking a decline from $1.42 in 2024. In the quarterly report ending on Mar 29, 2026, PFE's earnings per share amounted to $0.47.

Pfizer had an yealy earnings per share of $1.37, showing a decline of 3.5% from $1.42 recorded in 2024. The quarterly earnings per share for the period ending Mar 29, 2026, was $0.47, showing a 9.6% decline compared to the same quarter last year. The trailing twelve months EPS for PFE is $1.31 as of March 2026. Pfizer's full-year EPS for 2024 was $1.42, a 273.7% rise compared to the previous year.

Pfizer has recorded a decline in earnings per share of 9.6% in the past 12 months (YoY, quarterly). During the past three years, PFE registered an average yearly EPS growth of -37.4%. Pfizer had an average annual EPS growth of -3.7% in the last five years. Over the last decade, PFE had an average annual earnings per share growth of 1.9%.